155P: PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel–cisplatin chemotherapy

S. K. Do; S. Y. Lee; J. E. Choi; M. J. Hong; J. H. Lee; J. Y. Park

doi:10.1016/S1556-0864(16)30265-9

155P: PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel–cisplatin chemotherapy

S. K. Do
, S. Y. Lee
, J. E. Choi
, M. J. Hong
, J. H. Lee
, J. Y. Park

Department of Medicine

Kyungpook National University

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	S125
Journal	Journal of Thoracic Oncology
Volume	11
Issue number	4
DOIs	https://doi.org/10.1016/S1556-0864(16)30265-9
State	Published - Apr 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S1556-0864(16)30265-9

Cite this

@article{cb0645e4babc48b28efc8533d388b5d9,

title = "155P: PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel–cisplatin chemotherapy",

author = "Do, \{S. K.\} and Lee, \{S. Y.\} and Choi, \{J. E.\} and Hong, \{M. J.\} and Lee, \{J. H.\} and Park, \{J. Y.\}",

year = "2016",

month = apr,

doi = "10.1016/S1556-0864(16)30265-9",

language = "English",

volume = "11",

pages = "S125",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - 155P

T2 - PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel–cisplatin chemotherapy

AU - Do, S. K.

AU - Lee, S. Y.

AU - Choi, J. E.

AU - Hong, M. J.

AU - Lee, J. H.

AU - Park, J. Y.

PY - 2016/4

Y1 - 2016/4

UR - https://www.scopus.com/pages/publications/85029246459

U2 - 10.1016/S1556-0864(16)30265-9

DO - 10.1016/S1556-0864(16)30265-9

M3 - Article

AN - SCOPUS:85029246459

SN - 1556-0864

VL - 11

SP - S125

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 4

ER -

155P: PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel–cisplatin chemotherapy

UN SDGs

Access to Document

Other files and links

Cite this